Table 2 30-day postoperative mortality rates for patients undergoing surgery or biliary stenting by age group, year of diagnosis, hospital workload, workload of main treating consultant, and specialty of main treating consultant (P-values are shown for statistically significant differences)

From: Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study

 

Resectiona

Other surgerya

Biliary stenta

Factor

No. of cases

No. (%) of deaths

No. of cases

No. (%) of deaths

No. of cases

No. (%) of deaths

Age groups

  

P=0.016

 

P=0.023

 

 0–39

1

0

6

0

5

0

 40–49

14

2 (14%)

24

3 (13%)

19

2 (11%)

 50–59

30

1 (3%)

109

9 (8%)

78

7 (9%)

 60–69

63

4 (6%)

215

36 (17%)

202

22 (11%)

 70–79

21

3 (14%)

239

57 (24%)

261

51 (20%)

80

2

0

99

33 (33%)

175

45 (26%)

Year of diagnosis

  

P<0.001

 

P=0.001

 

 1993

21

2 (10%)

158

36 (23%)

119

21 (18%)

 1994

23

3 (13%)

153

43 (28%)

116

31 (27%)

 1995

24

3 (13%)

129

22 (17%)

148

29 (20%)

 1996

32

1 (3%)

144

23 (16%)

183

25 (14%)

 1997

31

1 (3%)

108

14 (13%)

174

21 (12%)

Caseload of hospital of treatment a

      

 1 case

0

N/A

0

N/A

0

N/A

 2–9 cases

0

N/A

10

2 (20%)

1

0

 10–29 cases

0

N/A

33

12 (36%)

18

4 (22%)

30 cases

131

10 (8%)

649

124 (19%)

721

123 (17%)

Caseload of main treating consultant a

  

P=0.014

   

 1 case

7

1 (14%)

102

21 (21%)

88

18 (21%)

 2–4 cases

11

3 (27%)

177

37 (21%)

112

24 (21%)

 5–9 cases

18

1 (6%)

176

47 (27%)

108

16 (15%)

10 cases

95

5 (5%)

237

33 (14%)

432

69 (16%)

Specialty of main treating consultant a

  

P=0.002

   

 Specialist

51

1 (2%)

86

6 (7%)

120

13 (11%)

 Clinician with an interest in the pancreas

32

2 (6%)

50

7 (14%)

33

7 (21%)

 Nonspecialist

48

7 (15%)

556

125 (23%)

587

107 (18%)

Total

131

10 (8%)

692

138 (20%)

740

127 (17%)

  1. aInformation derived from linked hospital discharge records does not include outpatient diagnostic or procedural information. Note that patients can appear in more than one of the treatment groups. N/A: not applicable.